Redeye hosts its second Regenerative Medicine / Cell Therapy event. Interesting companies in different areas within the theme will present.

 

The event will begin with an introduction by Julia Fransson from MSC Nordics. This is a unique opportunity for investors interested in this space to learn more, hopefully generating new investment ideas.

 

The participating companies will share their equity story, project status, and triggers ahead.

 

Following the presentations, Redeye’s analysts will hold Q&A sessions where questions are open to the audience.